Ashland Inc. (ASH)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
69.38
0.35 (0.51%)
At close: Jan 14, 2025, 3:59 PM
69.39
0.01%
After-hours Jan 14, 2025, 07:00 PM EST
Ashland Inc. Revenue Breakdown
Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intermediates And Solvents Revenue | 71.00M | 40.00M | 33.00M | 406.00M | 219.00M | 240.00M | 207.00M | 213.00M | 228.00M | 204.00M | 170.00M | 41.00M | 33.00M | 20.00M | 21.00M | 14.00M | 21.00M | 84.00M | 30.00M | 84.00M | 90.00M | 69.00M | 84.00M | 83.00M | 90.00M |
Intermediates And Solvents Revenue Growth | +77.50% | +21.21% | -91.87% | +85.39% | -8.75% | +15.94% | -2.82% | -6.58% | +11.76% | +20.00% | +314.63% | +24.24% | +65.00% | -4.76% | +50.00% | -33.33% | -75.00% | +180.00% | -64.29% | -6.67% | +30.43% | -17.86% | +1.20% | -7.78% | n/a |
Life Sciences Revenue | 388.00M | 222.00M | 200.00M | 288.00M | 152.00M | 161.00M | 143.00M | 187.00M | 194.00M | 182.00M | 156.00M | 58.00M | 60.00M | 60.00M | 51.00M | 60.00M | 58.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Life Sciences Revenue Growth | +74.77% | +11.00% | -30.56% | +89.47% | -5.59% | +12.59% | -23.53% | -3.61% | +6.59% | +16.67% | +168.97% | -3.33% | 0.00% | +17.65% | -15.00% | +3.45% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Personal Care And Household Revenue | 336.00M | 169.00M | 129.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.00M | 46.00M | 42.00M | 41.00M | 52.00M | 42.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Personal Care And Household Revenue Growth | +98.82% | +31.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +10.87% | +9.52% | +2.44% | -21.15% | +23.81% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Specialty Additives Revenue | 293.00M | 157.00M | 122.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 57.00M | 53.00M | 48.00M | 45.00M | 51.00M | 50.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Specialty Additives Revenue Growth | +86.62% | +28.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +7.55% | +10.42% | +6.67% | -11.76% | +2.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 |
---|---|---|---|---|---|---|---|---|---|
Non-Us Revenue | 1.49B | 1.56B | 1.66B | 637.00M | 878.00M | 959.00M | 1.42B | 2.01B | 2.39B |
Non-Us Revenue Growth | -4.37% | -6.20% | +160.60% | -27.45% | -8.45% | -32.46% | -29.42% | -15.71% | n/a |
United States Revenue | 624.00M | 634.00M | 731.00M | n/a | n/a | n/a | n/a | 1.25B | 2.56B |
United States Revenue Growth | -1.58% | -13.27% | n/a | n/a | n/a | n/a | n/a | -51.27% | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 105.00M | 69.00M | 87.00M | 83.00M | 109.00M | 84.00M | 79.00M | 93.00M | 94.00M | 127.00M | 90.00M | 82.00M | 85.00M | 98.00M | 84.00M | 106.00M | 109.00M | 113.00M | 103.00M | 99.00M | 109.00M | 150.00M | 136.00M | 143.00M | 235.00M | 203.00M | 163.00M | 171.00M | 177.00M | 182.00M | 245.00M | 239.00M | 502.00M | 244.00M | 258.00M | 224.00M | 383.00M | 216.00M | 203.00M |
Selling, General, and Administrative Revenue Growth | +52.17% | -20.69% | +4.82% | -23.85% | +29.76% | +6.33% | -15.05% | -1.06% | -25.98% | +41.11% | +9.76% | -3.53% | -13.27% | +16.67% | -20.75% | -2.75% | -3.54% | +9.71% | +4.04% | -9.17% | -27.33% | +10.29% | -4.90% | -39.15% | +15.76% | +24.54% | -4.68% | -3.39% | -2.75% | -25.71% | +2.51% | -52.39% | +105.74% | -5.43% | +15.18% | -41.51% | +77.31% | +6.40% | n/a |
Research and Development Revenue | 13.00M | 15.00M | 14.00M | 12.00M | 14.00M | 12.00M | 12.00M | 13.00M | 14.00M | 14.00M | 13.00M | 13.00M | 13.00M | 15.00M | 14.00M | 15.00M | 16.00M | 14.00M | 18.00M | 16.00M | 15.00M | 17.00M | 17.00M | 17.00M | 21.00M | 21.00M | 21.00M | 21.00M | 22.00M | 20.00M | 24.00M | 23.00M | 26.00M | 25.00M | 25.00M | 25.00M | 36.00M | 24.00M | 25.00M |
Research and Development Revenue Growth | -13.33% | +7.14% | +16.67% | -14.29% | +16.67% | n/a | -7.69% | -7.14% | n/a | +7.69% | n/a | n/a | -13.33% | +7.14% | -6.67% | -6.25% | +14.29% | -22.22% | +12.50% | +6.67% | -11.76% | n/a | n/a | -19.05% | n/a | n/a | n/a | -4.55% | +10.00% | -16.67% | +4.35% | -11.54% | +4.00% | n/a | n/a | -30.56% | +50.00% | -4.00% | n/a |
Sales and Marketing Revenue | 4.00M | -45.00M | -19.00M | n/a | 2.00M | 2.00M | n/a | n/a | 2.00M | n/a | n/a | n/a | 1.00M | n/a | n/a | n/a | -209.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.00M | n/a | n/a | n/a | 6.00M | n/a | n/a | n/a | 6.00M | n/a | n/a | n/a | 62.00M | n/a | n/a |
Sales and Marketing Revenue Growth | -108.89% | +136.84% | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a |